Active Fine Chemicals Limited (DSE:ACTIVEFINE)

Market Cap	1.85B -8.3%
Revenue (ttm)	1.35B -20.4%
Net Income	-4.54M
EPS	-0.02
Shares Out	239.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	604,244
Average Volume	625,437
Open	7.80
Previous Close	7.80
Day's Range	7.40 - 7.90
52-Week Range	4.70 - 10.30
Beta	-0.17
RSI	72.66
Earnings Date	n/a

About Active Fine Chemicals

Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hyd...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 92
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ACTIVEFINE

Financial Performance

In fiscal year 2022, Active Fine Chemicals's revenue was 1.67 billion, a decrease of -8.21% compared to the previous year's 1.82 billion. Earnings were 25.91 million, a decrease of -32.31%.